Drug Adverse Effects Glucocorticoid
From Anvita Health Wiki
Contents |
Adverse-effects
-
- may inhibit osteoblast activity
- may promote osteoblast apoptosis
- inhibition of intestinal Ca+2 transport [8]
- hypertension
- weight gain
- glucose intolerance/ diabetes mellitus
- depression
- central nervous system effects
- insomnia, anxiety, irritability (60%) [10]
- steroid psychosis
- bipolar symptoms
- begins 7-10 days after starting
- GI intolerance
- reduced tone of gastroesophageal sphincter
- gastroesophageal reflux
- upper GI bleed [5]
- accelerated atherogenesis
- immunosuppression
- disorder of neutrophil phagocytosis
- lymphopenia & monocytopenia
- decreased cell-mediated immunity
- opportunistic infections
- Cushingoid features:
-
- glucocorticoids synergistic with pregnancy
- impaired wound healing
- steroid myopathy
- increased risk of atrial fibrillation
- oral candidiasis
- dysphonia ( laryngeal myopathy)
- topical glucocorticoids may cause contact dermatitis (3-5%)
- inhaled glucocorticoids have no significant effect on final height or bone density in children [7]
- long-term effects or antenatal exposure may be minimal (see betamethasone)
Management
- Calcium 1.0-1.5 g QD & vitamin D 400-800 IU QD may be helpful & should be prescribed for vulnerable older adults taking equivalent of 7.5 mg of prednisone QD for 1 month or longer [8]
- alendronate (or other bisphosphonate) may reduce bone loss & reduce risk of fractures [4] & should be prescribed for vulnerable older adults taking equivalent of 7.5 mg of prednisone QD for 3 months or longer [8] unless contraindicated
More General Terms
References
- Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 792, 799
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- Journal Watch 21(6):46, 2001 Arthritis Rheum 44:202, 2001
- Journal Watch 21(14):118, 2001 Hernandez-Diaz & Rodriguez, Am J Epidemiol 153:1089, 2001
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Prescriber's Letter 9(8):48 2002
- Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004; 7th edition 2010
- Christiansen CF et al. Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study. Arch Intern Med 2009 Oct 12; 169:1677. PMID: [1]
- Prescriber's Letter 18(5): 2011 Corticosteroid-Induced Psychiatric Effects Detail-Document#: [2] (subscription needed) [3]
